4//SEC Filing
Bell John K 4
Accession 0001213900-18-015507
CIK 0001498382other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:35 PM ET
Size
5.4 KB
Accession
0001213900-18-015507
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Award
Options (Right to Buy)
2018-11-08+40,000→ 40,000 totalExercise: $0.61Exp: 2028-11-08→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001569585
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:35 PM ET
- Size
- 5.4 KB